1-13 of 13
thrombocytopenia due to immune destruction
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Clinical Trials & Observations
Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2794–2798.
https://doi.org/10.1182/bloodadvances.2021004957
Published: 2021
Journal Articles

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

Sabrina Shrestha, Ishac Nazy, James W. Smith, John G. Kelton, Donald M. Arnold
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2962–2966.
https://doi.org/10.1182/bloodadvances.2020001846
Published: 2020
Includes: Supplemental data
Journal Articles

Positivity rate of systematic bone marrow smear in patients over 60 years old with newly diagnosed immune thrombocytopenia

Clinical Trials & Observations
Thibault Comont, Johanne Germain, Odile Beyne-Rauzy, Daniel Adoue, Guillaume Moulis, and the CARMEN investigators group
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2136–2138.
https://doi.org/10.1182/bloodadvances.2020001654
Published: 2020
Journal Articles

Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.

Journal: Blood Advances
Blood Adv (2020) 4 (2): 252.
https://doi.org/10.1182/bloodadvances.2019001380
Published: 2020
Journal Articles

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia

Hanny Al-Samkari, Rachel P. Rosovsky, Rebecca S. Karp Leaf, David B. Smith, Katayoon Goodarzi, Annemarie E. Fogerty, David B. Sykes, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 4 (1): 9–18.
https://doi.org/10.1182/bloodadvances.2019000868
Published: 2019
Includes: Supplemental data
Journal Articles

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

Marie A. Hollenhorst, Hanny Al-Samkari, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3515–3521.
https://doi.org/10.1182/bloodadvances.2019000400
Published: 2019
Includes: Supplemental data
Journal Articles

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms

Clinical Trials & Observations
David E. Schmidt, Katja M. J. Heitink-Pollé, Annemieke G. Laarhoven, Marrie C. A. Bruin, Barbera Veldhuisen, Sietse Q. Nagelkerke, Taco W. Kuijpers, Leendert Porcelijn, C. Ellen van der Schoot, Gestur Vidarsson, Masja de Haas
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2003–2012.
https://doi.org/10.1182/bloodadvances.2019000068
Published: 2019
Includes: Supplemental data
Journal Articles

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Clinical Trials & Observations
Cindy E. Neunert, Melissa J. Rose
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1907–1915.
https://doi.org/10.1182/bloodadvances.2019000279
Published: 2019
Journal Articles

Dysregulated megakaryocyte distribution associated with nestin + mesenchymal stem cells in immune thrombocytopenia

Min Wang, Ru Feng, Jia-min Zhang, Lin-lin Xu, Fei-er Feng, Chen-cong Wang, Qian-ming Wang, Xiao-lu Zhu, Yun He, Jing Xue, Hai-xia Fu, Meng Lv, Yuan Kong, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu, Xiao-jun Huang, Xiao-hui Zhang
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1416–1428.
https://doi.org/10.1182/bloodadvances.2018026690
Published: 2019
Includes: Supplemental data
Journal Articles

Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1(24):2295-2301.

Journal: Blood Advances
Blood Adv (2018) 2 (15): 1817.
https://doi.org/10.1182/bloodadvances.2018023309
Published: 2018
Journal Articles

Eltrombopag for use in children with immune thrombocytopenia

Clinical Trials & Observations
Taylor Olmsted Kim, Jenny Despotovic, Michele P. Lambert
Journal: Blood Advances
Blood Adv (2018) 2 (4): 454–461.
https://doi.org/10.1182/bloodadvances.2017010660
Published: 2018
Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2295–2301.
https://doi.org/10.1182/bloodadvances.2017009860
Published: 2017
Journal Articles

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

Clinical Trials & Observations
Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S. Kaplan, James D. McFadyen, Huyen Tran, Tse-Chieh Teh, Shaun Fleming, John V. Catalano, Sanjeev D. Chunilal, Anna Johnston, Stephen S. Opat, Jake Shortt
Journal: Blood Advances
Blood Adv (2016) 1 (1): 31–35.
https://doi.org/10.1182/bloodadvances.2016001412
Published: 2016